Salona Global Medical Device Corporation
Symbol: SGMD.V
TSX
0.22
CADMarktpreis heute
-15.8062
P/E-Verhältnis
0.2483
PEG-Verhältnis
17.24M
MRK Kapital
- 0.00%
DIV Rendite
Salona Global Medical Device Corporation (SGMD-V) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 8.1 | 7.6 | 9.2 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.net-receivables | 0 | 7 | 0.1 | 0.1 | |||||||||
balance-sheet.row.inventory | 0 | 5 | 0 | 0 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 0 | 20 | 13.1 | 9.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5.4 | 0 | 0 | |||||||||
balance-sheet.row.goodwill | 0 | 9.8 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 6.9 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.8 | 0 | 0 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.5 | 0 | 0 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 22.6 | 0 | 0 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.account-payables | 0 | 2.9 | 0.5 | 0.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 5.9 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 4.6 | 0 | 0 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 13.6 | 6 | 0 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.4 | 0 | 0 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 4.2 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 0 | 29.5 | 6.5 | 0.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 38.5 | 31.1 | 31.1 | |||||||||
balance-sheet.row.retained-earnings | 0 | -33.4 | -29 | -26.9 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1 | 0.9 | 1.4 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7 | 3.6 | 3.4 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.total-debt | 0 | 10.5 | 0 | 0 | |||||||||
balance-sheet.row.net-debt | 0 | 2.5 | -7.1 | -8.3 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -4.4 | -2.7 | -1.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 1.2 | 0.2 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -0.2 | 1.3 | 1.3 | ||||||||
cash-flows.row.account-receivables | 0 | -2.1 | -2.1 | 0 | ||||||||
cash-flows.row.inventory | 0 | 0.2 | 0.2 | 0 | ||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-working-capital | 0 | 1.6 | 3.1 | 0 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1.1 | -0.5 | 0.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.acquisitions-net | 0 | -5.1 | -5.1 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.4 | -0.9 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.5 | 0.4 | 0 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 5.1 | 0 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4.6 | 0.1 | -0.9 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.5 | -2.5 | 0 | ||||||||
cash-flows.row.common-stock-issued | 0 | 4.3 | 4.3 | 0 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 2.2 | 3.7 | 0 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3.9 | 5.4 | 0 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -0.1 | -0.4 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | 0 | -4.4 | 4.2 | -1 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 8.1 | 12.5 | 8.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 12.5 | 8.3 | 9.3 | ||||||||
cash-flows.row.operating-cash-flow | 0 | -3.7 | -1 | -0.1 | ||||||||
cash-flows.row.capital-expenditure | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.free-cash-flow | 0 | -3.8 | -1 | -0.1 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 18.3 | 0 | 0.4 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 12.4 | 12.4 | 0.4 | ||||||||
income-statement-row.row.gross-profit | 0 | 6 | -12.4 | 0 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.operating-expenses | 0 | 6.6 | 1 | 1.7 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 18.9 | 1 | 2.1 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | -4.5 | -1 | -1.7 | ||||||||
income-statement-row.row.income-before-tax | 0 | -4.5 | -2.7 | -1.8 | ||||||||
income-statement-row.row.income-tax-expense | 0 | -0.1 | -0.1 | 0.6 | ||||||||
income-statement-row.row.net-income | 0 | -4.4 | -2.7 | -2.3 |
Häufig gestellte Frage
Wie hoch ist die Salona Global Medical Device Corporation (SGMD.V) Gesamtvermögen?
Salona Global Medical Device Corporation (SGMD.V) Gesamtvermögen ist 42681612.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.357.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.015.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.023.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -0.080.
Was ist der Salona Global Medical Device Corporation (SGMD.V) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -4372019.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 10533056.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 6570013.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.